American Society of Clinical Oncology

SHERPA: White

People

  1. Larson
    Larson
  2. Hudis
    Hudis
  3. Scher
    Scher
  4. Patil
    Patil
  5. Morris
    Morris
  6. Ginsberg
    Ginsberg
  7. Norton
    Norton
  8. Gonen
    Gonen
  9. Schoder
    Schoder
  10. Solomon
    Solomon

Groups

  1. Radiology, Department of (276)
  2. Solid Tumor Oncology Division (203)
  3. Body Imaging Service (144)
  4. Genitourinary Disease Management Team (125)
  5. Epidemiology and Biostatistics (116)
  6. Biostatistics Service (114)
  7. Molecular Imaging and Therapy Service (109)
  8. Head and Neck Cancer Disease Management Team (98)
  9. Thoracic Malignancies Disease Management Team (86)
  10. Central Nervous System Disease Management Team (84)
Search Within
Refine Results
  1. "Radiology, Department of"
Formats
  1. Meeting Abstract (174)
  2. Journal Article (102)
Groups
  1. Radiology, Department of (276)
  2. Solid Tumor Oncology Division (203)
  3. Body Imaging Service (144)
  4. Genitourinary Disease Management Team (125)
  5. Epidemiology and Biostatistics (116)
  6. Biostatistics Service (114)

More Groups

People
  1. Steven Larson (51)
  2. Howard Scher (36)
  3. Heiko Schoder (31)
  4. Michael Morris (31)
  5. Clifford Hudis (30)
  6. Sujata Patil (28)

More People

Years
  1. 2018 (8)
  2. 2017 (8)
  3. 2016 (13)
  4. 2015 (39)
  5. 2014 (31)
  6. 2013 (31)

More Years

Publications
  1. Journal of Clinical Oncology (272)
  2. American Society of Clinical Oncology Educational Book (4)

Results (276)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I/II clinical trial of ibrutinib and buparlisib in relapsed/refractory diffuse large B-cell lymphoma, mantle cell lymphoma, and follicular lymphoma
    Meeting Abstract

    Batlevi, C. L.; De Frank, S.; Stewart, C.; Hamlin, P. A.; Matasar, M. J.; Gerecitano, J. F.; Moskowitz, A. J.; Hamilton, A. M.; Zelenetz, A. D.; Drullinsky, P.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Ado-trastuzumab emtansine for patients with HER2-mutant lung cancers: Results from a phase II basket trial
    Journal Article

    Li, B. T.; Shen, R. L.; Buonocore, D.; Olah, Z. T.; Ni, A.; Ginsberg, M. S.; Ulaner, G. A.; Offin, M.; Feldman, D.; Hembrough, T.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Impact of baseline steroids on efficacy of programmed cell death-1 and programmed death-ligand 1 blockade in patients with non–small-cell lung cancer
    Journal Article

    Arbour, K. C.; Mezquita, L.; Long, N.; Rizvi, H.; Auclin, E.; Ni, A.; Martínez-Bernal, G.; Ferrara, R.; Lai, W. V.; Hendriks, L. E. L.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Multicenter prospective phase II trial of neoadjuvant dose-dense gemcitabine plus cisplatin in patients with muscle-invasive bladder cancer
    Journal Article

    Iyer, G.; Balar, A. V.; Milowsky, M. I.; Bochner, B. H.; Dalbagni, G.; Donat, S. M.; Herr, H. W.; Huang, W. C.; Taneja, S. S.; Woods, M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Alterations in DNA damage response and repair genes as potential marker of clinical benefit from PD-1/PD-L1 blockade in advanced urothelial cancers
    Journal Article

    Teo, M. Y.; Seier, K.; Ostrovnaya, I.; Regazzi, A. M.; Kania, B. E.; Moran, M. M.; Cipolla, C. K.; Bluth, M. J.; Chaim, J.; Al-Ahmadie, H.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Multicenter phase IB trial of carboxyamidotriazole orotate and temozolomide for recurrent and newly diagnosed glioblastoma and other anaplastic gliomas
    Journal Article

    Omuro, A.; Beal, K.; McNeill, K.; Young, R. J.; Thomas, A.; Lin, X.; Terziev, R.; Kaley, T. J.; DeAngelis, L. M.; Daras, M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Everolimus (E) plus bevacizumab (B) is effective first-line treatment for patients (pts) with advanced renal cell carcinoma (RCC) with papillary features (PF): Results from a phase II trial
    Meeting Abstract

    Feldman, D. R.; Lee, C. H.; Molina, A. M.; Knezevic, A.; Chen, Y.; Chaim, J.; Coskey, D. T.; Ged, Y.; Tickoo, S.; Reuter, V. E.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Molecular determinants of response to anti-programmed cell death (PD)-1 and anti-programmed death-ligand 1 (PD-L1) blockade in patients with non-small-cell lung cancer profiled with targeted next-generation sequencing
    Journal Article

    Rizvi, H.; Sanchez-Vega, F.; La, K.; Chatila, W.; Jonsson, P.; Halpenny, D.; Plodkowski, A.; Long, N.; Sauter, J. L.; Rekhtman, N.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Total neoadjuvant chemotherapy to facilitate delivery and tolerance of systemic chemotherapy and response in locally advanced rectal cancer
    Meeting Abstract

    Cercek, A.; Roxburgh, C. S. D.; Strombom, P.; Smith, J. J.; Temple, L. K. F.; Nash, G. M.; Guillem, J. G.; Paty, P.; Yaeger, R.; Stadler, Z. K.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Quantitative assessment of early [(18)F]sodium fluoride positron emission tomography/computed tomography response to treatment in men with metastatic prostate cancer to bone
    Journal Article

    Harmon, S. A.; Perk, T.; Lin, C.; Eickhoff, J.; Choyke, P. L.; Dahut, W. L.; Apolo, A. B.; Humm, J. L.; Larson, S. M.; Morris, M. J.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save